methods for treating depression, for increasing monoamine neurotransmitter levels, and for selectively inhibiting biogenic amine reuptake, agent, composition, and unit oral dosage form
ANTHONY ALEXANDER MCKINNEY,FRANK BYMASTER,WALTER PISKORSKI
申请号:
BR112013013572
公开号:
BR112013013572A2
申请日:
2011.12.02
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable active salts, polymorphs, glycosylated derivatives, metabolites, solvates, hydrates, and/or prodrugs of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and their use alone or in combination with additional psychotherapeutic compositions in the treatment of conditions affected by monoamine neurotransmitters, including treatment of refractory individuals.